Last updated: June 2026
If CBG is the “mother of all cannabinoids,” CBGa is the mother of CBG itself — the foundational molecule from which all major cannabinoids are formed. Here’s everything you need to know about this fascinating precursor compound.
Evopure CBD — broad-spectrum with minor cannabinoids
What is CBGa?
CBGa (cannabigerolic acid) is the foundational precursor molecule from which all major cannabinoids are formed. It is produced in the trichomes of young cannabis and hemp plants. As the plant matures, CBGa is converted by enzymes into THCa, CBDa and CBCa — the acidic precursors of THC, CBD and CBC respectively. A small proportion converts into CBGa’s own non-acidic form, CBG.
CBGa also performs a structural plant function: it triggers cell necrosis in leaves, directing the plant’s energy reserves toward the flowers and cannabinoid-rich trichomes as they mature. Without CBGa, CBD and THC simply wouldn’t exist.
Read more: CBD vs THC | CBG vs CBD
Is CBGa a cannabinoid?
Technically, CBGa is not a cannabinoid itself — it is a cannabinoid precursor or foundational molecule. While cannabinoids are the active compounds that interact with the endocannabinoid system (like CBD or THC), CBGa is the upstream molecule that converts into those cannabinoids through enzymatic processes. Think of it as the raw material from which the cannabinoid family is built.
Potential benefits of CBGa
CBGa is attracting growing research interest across several areas. All findings are preliminary and no clinical conclusions can yet be drawn:
Cardiovascular health
CBGa has been studied for its ability to inhibit aldose reductase — an enzyme that contributes to oxidative stress and is linked to heart problems. This suggests potential cardiovascular protective applications.
Metabolic disorders
A 2019 computer simulation study found CBGa may help activate PPAR receptors, which dysfunction in conditions like type 2 diabetes and dyslipidemia, suggesting potential therapeutic relevance for metabolic disorders.
Colorectal cancer
Laboratory studies found CBGa had cytotoxic effects on colon cancer cells — promoting early cell death, arresting the cancer cell cycle and preventing the growth of polyps. This is very early-stage research.
COVID-19 (preliminary)
CBGa and CBDa were investigated for their potential to bind to SARS-CoV-2 spike proteins. When human cells were incubated with either compound, the virus was undetectable after 24 hours in laboratory conditions — though these findings are very early and not clinically proven.
Curious about the full range of hemp plant compounds?
Evopure broad-spectrum CBD retains minor cannabinoids and terpenes alongside CBD. Take our quiz to find the right formula.
Take the free health quiz →Effects of CBGa
CBGa is non-psychoactive — it will not make you feel high. Its effects are thought to act primarily outside the endocannabinoid system (it does not interact meaningfully with CB1 or CB2 receptors). Research into its standalone effects when consumed is still in very early stages. Currently, CBGa is not available as an isolated retail supplement in the UK.
Read more: What is the endocannabinoid system?
CBG vs CBGa — what’s the difference?
They are related but structurally different molecules. CBGa is the acidic form found in young hemp plants. When exposed to heat or light (decarboxylation), CBGa loses its carboxylic acid group and converts to CBG — the non-acidic, active cannabinoid. CBGa is the precursor; CBG is the final compound. The two have different molecular structures and are associated with different properties in research.
CBD vs CBGa — are they comparable?
Not directly — they operate at different levels of the cannabinoid hierarchy. CBGa is a precursor molecule that converts into cannabinoids (including CBD). CBD is the finished active cannabinoid that interacts with the ECS. CBGa also serves a unique structural plant function — triggering leaf cell death to direct energy toward flowers and trichomes — which CBD does not. As the research matures, the relationship between these molecules will become better understood.
Frequently asked questions
Is CBGa the same as CBG?
No. CBGa is the acidic precursor that converts to CBG (and other cannabinoids) through heat and light. CBG is the non-acidic, active form. They are structurally different molecules with different properties.
Is CBGa psychoactive?
No — CBGa is non-psychoactive and will not produce a high.
Can I buy CBGa as a supplement in the UK?
Isolated CBGa is not available as a retail supplement in the UK. It exists primarily in raw young hemp plant material and early-stage extracts.
What is CBGa being researched for?
Early-stage investigations include cardiovascular protection (aldose reductase inhibition), metabolic disorders (PPAR activation), colorectal cancer models, and binding to SARS-CoV-2 spike proteins. All findings remain preliminary.
Does CBGa interact with the endocannabinoid system?
Current evidence suggests CBGa’s effects operate mostly outside CB1/CB2 receptor activity — unlike CBD and THC which interact more directly with the ECS. Research is still very early.
Interested in the full spectrum of hemp plant compounds?
Take our free quiz and we’ll recommend the right Evopure broad-spectrum formula for your goals.
Take the free health quiz →Final thoughts on CBGa
CBGa is the foundational molecule that makes all cannabinoids possible — including CBD, THC and CBG. Research into its own direct therapeutic potential is genuinely exciting, spanning cardiovascular, metabolic and anticancer applications. As the cannabinoid science matures, CBGa may prove to be one of the most significant compounds in the hemp plant. For now, the best way to benefit from the full complement of plant compounds is broad-spectrum CBD — which retains the widest range of cannabinoids alongside CBD.
